Dextrose and morrhuate sodium injections (Prolotherapy) for knee osteoarthritis: A prospective open-label trial

Keyphrases

• Sodium 100%
• Knee Osteoarthritis 100%
• Dextrose 100%
• Open-label Trial 100%
• Prolotherapy 100%
• WOMAC 66%
• Randomized Controlled Trial 50%
• Knee Pain 50%
• Opioid Medication 33%
• Knee Function 33%
• Knee Stiffness 33%
• Adverse Events 16%
• Tendon 16%
• Ligament 16%
• Medication Use 16%
• Osteoarthritis 16%
• Sustained Improvement 16%
• Participant Satisfaction 16%
• Change Score 16%
• Intra-articular Injection 16%
• Primary Outcome Measure 16%
• Periarticular 16%
• 1-year Follow-up 16%
• Uncontrolled Study 16%
• Injection Pain 16%
• Pain Scale 16%
• Extra-articular 16%
• McMaster University 16%
• Western Ontario 16%
• Minimal Clinically Important Difference 16%
• Injection Schedules 16%
• Symptomatic Knee Osteoarthritis 16%
• Prolotherapy Injections 16%

Medicine and Dentistry

• Randomized Controlled Trial 100%
• Knee Osteoarthritis 100%
• Glucose 100%
• Open-Label Trial 100%
• Western Ontario and McMaster Universities Osteoarthritis Index 57%
• Knee Pain 42%
• Adverse Event 14%
• Arm 14%
• Outpatient 14%
• Intra-Articular Injection 14%
• Osteoarthritis 14%
• Pain Assessment 14%

Nursing and Health Professions

• Knee Osteoarthritis 100%
• Glucose 100%
• Open-Label Trial 100%
• Western Ontario and McMaster Universities Osteoarthritis Index 80%
• Knee Pain 60%
• Rigidity 40%
• Adverse Event 20%
• Outpatient 20%
• Osteoarthritis 20%
• Pain Assessment 20%
• Intraarticular Drug Administration 20%